1253197-31-7Relevant articles and documents
NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES
-
, (2017/03/21)
The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.
NR2B-SELECTIVE NMDA-RECEPTOR ANTAGONISTS
-
Page/Page column 54, (2010/11/05)
The present invention relates to compounds according to general formula (I) and pharmaceutical compositions comprising compounds according to general formula (I).